Cue Biopharma Vs. GlycoMimetics Industry Stock Comparison

Sell

28

CUE
Cue Biopharma

Last Price:

1.23

Seasonality Move:

14.02%

Sell

50

GLYC
GlycoMimetics

Last Price:

0.31

Seasonality Move:

11.03%

Sell

28

Cue Biopharma (CUE) is a Sell

Is Cue Biopharma a Buy, Sell or Hold?

The current Cue Biopharma [CUE] share price is $1.09. The Score for CUE is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
CUE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

50

GlycoMimetics (GLYC) is a Sell

Is GlycoMimetics a Buy, Sell or Hold?

The current GlycoMimetics [GLYC] share price is $0.32. The Score for GLYC is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
GLYC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

CUE Stock Price Chart

What is Cue Biopharma's stock price today?

The Cue Biopharma share price today is $1.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing slight buying pressure.

GLYC Stock Price Chart

What is GlycoMimetics's stock price today?

The GlycoMimetics share price today is $0.32
The current trend is moderately bearish and GLYC is experiencing slight buying pressure.

CUE Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.08	Sell
Relative Strength Index (14 RSI):	40.82	Sell
Chaikin Money Flow:	0	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(1.18 - 1.74)	Sell
Bollinger Bands (100):	(0.57 - 1.35)	Buy

GLYC Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	0.02	Buy
Relative Strength Index (14 RSI):	48.97	Sell
Chaikin Money Flow:	296581	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(0.26 - 0.44)	Sell
Bollinger Bands (100):	(0.14 - 0.32)	Buy

CUE Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	1.09	Buy
20-day SMA:	1.42	Sell
50-day SMA:	1.2	Sell
200-day SMA:	1.36	Sell
8-day EMA:	1.15	Sell
20-day EMA:	1.29	Sell
50-day EMA:	1.23	Sell
200-day EMA:	1.44	Sell

GLYC Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	0.35	Sell
20-day SMA:	0.38	Sell
50-day SMA:	0.26	Buy
200-day SMA:	0.93	Sell
8-day EMA:	0.34	Sell
20-day EMA:	0.34	Sell
50-day EMA:	0.3	Buy
200-day EMA:	0.73	Sell

Cue Biopharma Earnings Growth & CUE Earnings Dates

Analysts estimate an earnings increase this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and an increase next year of $0.19 per share.

GlycoMimetics Earnings Growth & GLYC Earnings Dates

Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.01 per share.

Cue Biopharma Technical Analysis

	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26
	Nov
	13	14	15	18	19	20	21	22	25	26
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

GlycoMimetics Technical Analysis

	Nov 13	Nov 14	Nov 15	Nov 18	Nov 19	Nov 20	Nov 21	Nov 22	Nov 25	Nov 26
	Nov
	13	14	15	18	19	20	21	22	25	26
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):